,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,,,,,,,,,,,C,"N-degron, 1-3, ELM",,,,,,,,,,,
1,2,L,,,,,,,,,,,C,"N-degron, 1-3, ELM",,,,,,,,,,,
2,3,L,,,,,,,,,,,C,"N-degron, 1-3, ELM|Calcineurin (PP2B)-docking motif LxvP, 3-6, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,,,,,,,,,,
3,4,S,,,,,,,,,,,C,"Calcineurin (PP2B)-docking motif LxvP, 3-6, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,,,,,,,,,,
4,5,V,A,,,,,,,,,,C,"Calcineurin (PP2B)-docking motif LxvP, 3-6, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,COSMIC,,,"hg38,19:12938693-12938693","hg38,19:g.12938693T>C",,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, mycosis_fungoides-Sezary_syndrome",,
5,5,V,M,,,,,,,,,,C,"Calcineurin (PP2B)-docking motif LxvP, 3-6, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,cBioPortal,"ucs_tcga, ucs_tcga_pan_can_atlas_2018",Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,"hg19,19:13049506-13049506","hg19,19:g.13049506G>A",0.080,,,,
6,6,P,,,,,,,,,,,C,"Calcineurin (PP2B)-docking motif LxvP, 3-6, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,,,,,,,,,,
7,7,L,P,,,,,,,,,,C,"Nuclear receptor box, 7-13, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,19:13049513-13049513","hg19,19:g.13049513T>C",0.266,,,,
8,8,L,V,,,,,,,,,,C,"Nuclear receptor box, 7-13, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 3-8, ELM",,cBioPortal,nsclc_mskcc_2018,Non-Small Cell Lung Cancer,"hg19,19:13049515-13049515","hg19,19:g.13049515C>G",,,,,0.0000318613394507
9,9,L,,,,,,,,,,,C,"Nuclear receptor box, 7-13, ELM",,,,,,,,,,,
10,10,G,D,,,,,,,,,,C,"Nuclear receptor box, 7-13, ELM",,COSMIC,,,"hg38,19:12938708-12938708","hg38,19:g.12938708G>A",0.157,stomach,carcinoma,,
11,11,L,,,,,,,,,,,D,"Nuclear receptor box, 7-13, ELM",,,,,,,,,,,
12,12,L,F,,,,,,,,,,D,"Nuclear receptor box, 7-13, ELM",,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,19:13049527-13049527, hg38,19:12938713-12938713","hg19,19:g.13049527C>T, hg38,19:g.12938713C>T",0.043,"large_intestine, ovary","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma",0.0000041824904221,
13,13,G,C,,,,,,,,,,D,"Nuclear receptor box, 7-13, ELM|SH3 ligand, 13-19, ELM",,cBioPortal,"cfdna_msk_2019, msk_met_2021",Mixed Cancer Types,"hg19,19:13049530-13049530","hg19,19:g.13049530G>T",0.190,,,,
14,13,G,R,,,,,,,,,,D,"Nuclear receptor box, 7-13, ELM|SH3 ligand, 13-19, ELM",,"cBioPortal,COSMIC","egc_msk_2017, msk_impact_2017","Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,19:13049530-13049530, hg38,19:12938716-12938716","hg19,19:g.13049530G>C, hg38,19:g.12938716G>C",0.287,stomach,"carcinoma, adenocarcinoma",,
15,13,G,V,,,,,,,,,,D,"Nuclear receptor box, 7-13, ELM|SH3 ligand, 13-19, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13049531-13049531","hg19,19:g.13049531G>T",0.124,,,,
16,14,L,,,,,,,,,,,D,"SH3 ligand, 13-19, ELM",,,,,,,,,,,
17,15,A,,,,,,,,,,,D,"SH3 ligand, 13-19, ELM",,,,,,,,,,,
18,16,V,,,,,,,,,,,D,"SH3 ligand, 13-19, ELM",,,,,,,,,,,
19,17,A,,,,,,,,,,,D,"SH3 ligand, 13-19, ELM",,,,,,,,,,,
20,18,E,,,,,,,,,,,C,"SH3 ligand, 13-19, ELM",,,,,,,,,,,
21,19,P,S,,,,,,,,,,C,"SH3 ligand, 13-19, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13049548-13049548","hg19,19:g.13049548C>T",,,,,
22,20,A,V,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13049552-13049552","hg19,19:g.13049552C>T",0.086,,,,
23,21,V,,,,,,,,,,,C,,,,,,,,,,,,
24,22,Y,,P,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 22-25, ELM",,,,,,,,,,,
25,23,F,L,,,,,,,,,,C,"Pex14 ligand motif, 23-27, ELM|Phosphotyrosine ligands bound by SH2 domains, 22-25, ELM",,cBioPortal,breast_ink4_msk_2021,Breast,"hg19,19:13049562-13049562","hg19,19:g.13049562C>G",0.160,,,,
26,24,K,,,,Ubq,,,,Sumo,,,C,"Pex14 ligand motif, 23-27, ELM|Phosphotyrosine ligands bound by SH2 domains, 22-25, ELM",,,,,,,,,,,
27,25,E,K,,,,,,,,,,C,"Pex14 ligand motif, 23-27, ELM|Phosphotyrosine ligands bound by SH2 domains, 22-25, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13049566-13049566","hg19,19:g.13049566G>A",0.691,,,,
28,26,Q,,,,,,,,,,,C,"Pex14 ligand motif, 23-27, ELM",,,,,,,,,,,
29,27,F,I,,,,,,,,,,C,"Pex14 ligand motif, 23-27, ELM",,cBioPortal,sarcoma_mskcc_2022,Soft Tissue,"hg19,19:13049572-13049572","hg19,19:g.13049572T>A",0.872,,,,
30,27,F,L,,,,,,,,,,C,"Pex14 ligand motif, 23-27, ELM",,"cBioPortal,COSMIC","pancan_pcawg_2020, panet_arcnet_2017","Mixed Cancer Types, Pancreatic Neuroendocrine Tumor","hg19,19:13049572-13049572, hg38,19:12938758-12938758","hg19,19:g.13049572T>C, hg38,19:g.12938758T>C",0.835,pancreas,carcinoid-endocrine_tumour,,
31,28,L,R,,,,,,,,,,C,,,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:13049576-13049576","hg19,19:g.13049576T>G",0.212,,,,
32,29,D,,,,,,,,,,,C,,,,,,,,,,,,
33,30,G,R,,,,,,,,,,C,,,cBioPortal,"msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,19:13049581-13049581","hg19,19:g.13049581G>A",0.400,,,0.0000000000000000,
34,31,D,E,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13049949-13049949","hg19,19:g.13049949C>G",0.195,,,,
35,31,D,N,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,19:13049584-13049584, hg38,19:12938770-12938770","hg19,19:g.13049584G>A, hg38,19:g.12938770G>A",0.254,,malignant_melanoma,,
36,32,G,V,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,19:13049951-13049951","hg19,19:g.13049951G>T",0.152,,,,
37,33,W,,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,,,,,,,,,,
38,34,T,A,P,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,COSMIC,,,"hg38,19:12939142-12939142","hg38,19:g.12939142A>G",0.024,stomach,carcinoma,,
39,34,T,N,P,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,"cBioPortal,COSMIC","laml_tcga_pan_can_atlas_2018, mds_mskcc_2020","Acute Myeloid Leukemia, Myelodysplastic Syndromes","hg19,19:13049957-13049957, hg38,19:12939143-12939143","hg19,19:g.13049957C>A, hg38,19:g.12939143C>A",0.071,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0000041947364447,
40,34,T,S,P,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13049956-13049956","hg19,19:g.13049956A>T",,,,,
41,35,S,F,P,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, sarcoma_mskcc_2022","Cutaneous Melanoma, Mixed Cancer Types, Soft Tissue","hg19,19:13049960-13049960, hg38,19:12939146-12939146","hg19,19:g.13049960C>T, hg38,19:g.12939146C>T",,skin,"carcinoma, basal_cell_carcinoma",,
42,35,S,N,P,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13049959-13049960","hg19,19:g.13049959_13049960delinsAA",,,,,
43,36,R,,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,,,,,,,,,,
44,37,W,G,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 31-37, ELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13049965-13049965","hg19,19:g.13049965T>G",0.869,,,,
45,38,I,,,,,,,,,,,C,,,,,,,,,,,,
46,39,E,K,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13049971-13049971","hg19,19:g.13049971G>A",0.148,,,,
47,40,S,F,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13049975-13049975","hg19,19:g.13049975C>T",0.816,,,,
48,41,K,,,,Ubq,,,,,,,C,,,,,,,,,,,,
49,42,H,Y,,,,,,,,,,C,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13049980-13049980","hg19,19:g.13049980C>T",0.231,,,,
50,43,K,,,,,,,,,,,C,,,,,,,,,,,,
51,44,S,,P,,,,,,,,,C,,,,,,,,,,,,
52,45,D,Y,,,,,,,,,,C,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,19:13049989-13049989, hg38,19:12939175-12939175","hg19,19:g.13049989G>T, hg38,19:g.12939175G>T",0.467,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, acute_lymphoblastic_leukaemia",,
53,46,F,Y,,,,,,,,,,C,,,"cBioPortal,COSMIC",lcll_broad_2013,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"hg19,19:13049993-13049993, hg38,19:12939179-12939179","hg19,19:g.13049993T>A, hg38,19:g.12939179T>A",0.041,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,
54,47,G,D,,,,,,,,,,C,,,cBioPortal,"msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,19:13049996-13049996","hg19,19:g.13049996G>A",0.793,,,,
55,48,K,,,,Ubq,,,Ac,,,,C,"PCSK cleavage site, 48-52, ELM",,,,,,,,,,,
56,49,F,L,,,,,,,,,,C,"PCSK cleavage site, 48-52, ELM",,cBioPortal,nsclc_ctdx_msk_2022,Non-Small Cell Lung Cancer,"hg19,19:13050003-13050003","hg19,19:g.13050003C>G",0.333,,,,
57,50,V,,,,,,,,,,,C,"PCSK cleavage site, 48-52, ELM",,,,,,,,,,,
58,51,L,V,,,,,,,,,,C,"PCSK cleavage site, 48-52, ELM",,"cBioPortal,COSMIC","lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub",Diffuse Glioma,"hg19,19:13050007-13050007, hg38,19:12939193-12939193","hg19,19:g.13050007C>G, hg38,19:g.12939193C>G",0.120,"central_nervous_system, brain",glioma,,
59,52,S,,P,,,,,,,,,C,"PCSK cleavage site, 48-52, ELM|BRCT phosphopeptide ligands, 52-56, ELM",,,,,,,,,,,
60,53,S,F,P,,,,,,,,,C,"BRCT phosphopeptide ligands, 52-56, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,19:13050014-13050014","hg19,19:g.13050014C>T",0.315,,,,
61,54,G,V,,,,,,,,,,C,"BRCT phosphopeptide ligands, 52-56, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050017-13050017","hg19,19:g.13050017G>T",0.773,,,,
62,55,K,,,,Ubq,,,Ac,,,,C,"BRCT phosphopeptide ligands, 52-56, ELM",,,,,,,,,,,
63,56,F,L,,,,,,,,,,C,"BRCT phosphopeptide ligands, 52-56, ELM",,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,19:13050024-13050024, hg38,19:12939210-12939210","hg19,19:g.13050024C>A, hg38,19:g.12939210C>A",0.260,skin,malignant_melanoma,0.0000040577828275,
64,57,Y,C,P,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv","blca_bcan_hcrn_2022, nsclc_tracerx_2017","Bladder Urothelial Carcinoma, Non-Small Cell Lung Cancer","hg19,19:13050026-13050026","hg19,19:g.13050026A>G",0.471,,,0.0005765467287063,0.0001273723092600
65,58,G,,,,,,,,,,,C,,,,,,,,,,,,
66,59,D,Y,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050031-13050031","hg19,19:g.13050031G>T",,,,,
67,60,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,19:13050034-13050034, hg38,19:12939220-12939220","hg19,19:g.13050034G>A, hg38,19:g.12939220G>A",,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
68,61,E,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12939224-12939224","hg38,19:g.12939224A>G",0.169,"large_intestine, rectum","carcinoma, adenocarcinoma",,
69,61,E,K,,,,,,,,,,C,,,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13050037-13050037","hg19,19:g.13050037G>A",0.217,,,,
70,62,K,N,,,Ubq,,,Ac,,,,C,,,"cBioPortal,COSMIC",brca_tcga,Invasive Breast Carcinoma,"hg19,19:13050042-13050042, hg38,19:12939228-12939228","hg19,19:g.13050042A>C, hg38,19:g.12939228A>C",0.121,breast,carcinoma,,
71,62,K,R,,,Ubq,,,Ac,,,,C,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:13050041-13050041, hg38,19:12939227-12939227","hg19,19:g.13050041A>G, hg38,19:g.12939227A>G",0.166,endometrium,"carcinoma, endometrioid_carcinoma",,
72,63,D,H,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12939229-12939229","hg38,19:g.12939229G>C",,lung,carcinoma,,
73,64,K,T,,,Ubq,,,Ac,,,,C,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:13050047-13050047, hg38,19:12939233-12939233","hg19,19:g.13050047A>C, hg38,19:g.12939233A>C",,"large_intestine, colon","carcinoma, adenocarcinoma",,
74,65,G,C,,,,,,,,,,C,,,cBioPortal,coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:13050049-13050049","hg19,19:g.13050049G>T",0.908,,,,
75,66,L,,,,,,,,,,,C,"FHA phosphopeptide ligands, 66-72, ELM",,,,,,,,,,,
76,67,Q,H,,,,,,,,,,C,"FHA phosphopeptide ligands, 66-72, ELM",,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:13050249-13050249, hg38,19:12939435-12939435","hg19,19:g.13050249G>C, hg38,19:g.12939435G>C",0.379,cervix,"carcinoma, squamous_cell_carcinoma",,
77,68,T,,,,,,,,,,,C,"Caspase cleavage motif, 68-72, ELM|FHA phosphopeptide ligands, 66-72, ELM",,,,,,,,,,,
78,69,S,N,,,,,,,,,,C,"Caspase cleavage motif, 68-72, ELM|FHA phosphopeptide ligands, 66-72, ELM",,COSMIC,,,"hg38,19:12939440-12939440","hg38,19:g.12939440G>A",0.250,"eye, conjunctiva",malignant_melanoma,,
79,70,Q,,,,,,,,,,,C,"Caspase cleavage motif, 68-72, ELM|FHA phosphopeptide ligands, 66-72, ELM",,,,,,,,,,,
80,71,D,G,,,,,,,,,,C,"Caspase cleavage motif, 68-72, ELM|FHA phosphopeptide ligands, 66-72, ELM",,COSMIC,,,"hg38,19:12939446-12939446","hg38,19:g.12939446A>G",0.533,large_intestine,"carcinoma, adenocarcinoma",0.0000039770603161,
81,72,A,G,,,,,,,,,,C,"Caspase cleavage motif, 68-72, ELM|FHA phosphopeptide ligands, 66-72, ELM",,COSMIC,,,"hg38,19:12939449-12939449","hg38,19:g.12939449C>G",0.304,pleura,"mesothelioma, biphasic",,
82,73,R,,,Me,,,,,,,,C,,,,,,,,,,,,
83,74,F,,,,,,,,,,,C,,,,,,,,,,,,
84,75,Y,,P,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 75-79, ELM",,,,,,,,,,,
85,76,A,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 75-79, ELM",,,,,,,,,,,
86,77,L,V,,,,,,,,,,C,"BRCT phosphopeptide ligands, 77-81, ELM|Phosphotyrosine ligands bound by SH2 domains, 75-79, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050277-13050277","hg19,19:g.13050277C>G",0.042,,,,
87,78,S,,P,,,,,,,,,C,"BRCT phosphopeptide ligands, 77-81, ELM|Phosphotyrosine ligands bound by SH2 domains, 75-79, ELM",,,,,,,,,,,
88,79,A,,,,,,,,,,,C,"BRCT phosphopeptide ligands, 77-81, ELM|Phosphotyrosine ligands bound by SH2 domains, 75-79, ELM",,,,,,,,,,,
89,80,S,,P,,,,,,,,,C,"BRCT phosphopeptide ligands, 77-81, ELM",,,,,,,,,,,
90,81,F,,,,,,,,,,,C,"BRCT phosphopeptide ligands, 77-81, ELM",,,,,,,,,,,
91,82,E,Q,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,19:13050292-13050292, hg38,19:12939478-12939478","hg19,19:g.13050292G>C, hg38,19:g.12939478G>C",0.067,"autonomic_ganglia, adrenal_gland",neuroblastoma,,
92,82,E,V,,,,,,,,,,C,,,cBioPortal,lung_msk_pdx,Lung,"hg19,19:13050293-13050293","hg19,19:g.13050293A>T",0.220,,,,
93,83,P,,,,,,,,,,,C,,,,,,,,,,,,
94,84,F,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,19:13050300-13050300, hg38,19:12939486-12939486","hg19,19:g.13050300C>G, hg38,19:g.12939486C>A",0.250,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma, non_papillary_transitional_cell_carcinoma_non_invasive",,
95,85,S,I,P,,,,,,,,,C,,,COSMIC,,,"hg38,19:12939488-12939488","hg38,19:g.12939488G>T",,liver,"other, neoplasm",,
96,86,N,,,,,,,,,,,C,,,,,,,,,,,,
97,87,K,,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM",,,,,,,,,,,
98,88,G,,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM",,,,,,,,,,,
99,89,Q,,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM",,,,,,,,,,,
100,90,T,A,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM|Atg8 protein family ligands, 90-93, ELM",,"cBioPortal,COSMIC",pptc_2019,Mixed Cancer Types,"hg19,19:13050316-13050316, hg38,19:12939502-12939502","hg19,19:g.13050316A>G, hg38,19:g.12939502A>G",0.134,thyroid,carcinoma,0.0000079529819706,
101,90,T,M,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM|Atg8 protein family ligands, 90-93, ELM",,COSMIC,,,"hg38,19:12939503-12939503","hg38,19:g.12939503C>T",0.381,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelodysplastic_syndrome",0.0003300487517795,0.0000318491623670
102,91,L,M,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM|Atg8 protein family ligands, 90-93, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13050319-13050319","hg19,19:g.13050319C>A",,,,,
103,92,V,,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM|Atg8 protein family ligands, 90-93, ELM",,,,,,,,,,,
104,93,V,M,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM|Atg8 protein family ligands, 90-93, ELM",,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,19:13050325-13050325, hg38,19:12939511-12939511","hg19,19:g.13050325G>A, hg38,19:g.12939511G>A",0.420,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000516919161796,
105,94,Q,,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM|FHA phosphopeptide ligands, 88-94, ELM",,,,,,,,,,,
106,95,F,,,,,,,,,,,C,"MAPK docking motifs, 87-95, ELM",,,,,,,,,,,
107,96,T,,,,,,,,,,,C,,,,,,,,,,,,
108,97,V,,,,,,,,,,,C,,,,,,,,,,,,
109,98,K,,,,,,,,,,,C,,,,,,,,,,,,
110,99,H,D,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050343-13050343","hg19,19:g.13050343C>G",0.568,,,,
111,100,E,Q,,,,,,,,,,C,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:13050346-13050346, hg38,19:12939532-12939532","hg19,19:g.13050346G>C, hg38,19:g.12939532G>C",0.251,cervix,"carcinoma, squamous_cell_carcinoma",,
112,101,Q,R,,,,,,,,,,C,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:13050350-13050350, hg38,19:12939536-12939536","hg19,19:g.13050350A>G, hg38,19:g.12939536A>G",0.553,lung,"carcinoma, squamous_cell_carcinoma",,
113,102,N,,,,,,,,,,,C,,,,,,,,,,,,
114,103,I,T,,,,,,,,,,C,,,cBioPortal,"coadread_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:13050356-13050356","hg19,19:g.13050356T>C",,,,,
115,104,D,,,,,,,,,,,C,,,,,,,,,,,,
116,105,C,W,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050363-13050363","hg19,19:g.13050363T>G",0.832,,,,
117,106,G,R,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,19:13050364-13050364, hg38,19:12939550-12939550","hg19,19:g.13050364G>A, hg38,19:g.12939550G>A",0.746,,"carcinoma, of_unknown_primary",,
118,106,G,V,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:13050365-13050365, hg38,19:12939551-12939551","hg19,19:g.13050365G>T, hg38,19:g.12939551G>T",0.783,large_intestine,"carcinoma, adenocarcinoma",,
119,107,G,,,,,,,,,,,C,,,,,,,,,,,,
120,108,G,,,,,,,,,,,C,,,,,,,,,,,,
121,109,Y,,P,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Y-based sorting signal, 109-112, ELM",,,,,,,,,,,
122,110,V,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Y-based sorting signal, 109-112, ELM",,,,,,,,,,,
123,111,K,R,,Me,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Y-based sorting signal, 109-112, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13050380-13050380, hg38,19:12939566-12939566","hg19,19:g.13050380A>G, hg38,19:g.12939566A>G",0.768,endometrium,"carcinoma, endometrioid_carcinoma",,
124,112,L,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Phosphotyrosine ligands bound by SH2 domains, 109-112, ELM|Y-based sorting signal, 109-112, ELM",,,,,,,,,,,
125,113,F,,,,,,,,,,,C,,,,,,,,,,,,
126,114,P,L,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12939575-12939575","hg38,19:g.12939575C>T",0.488,liver,"other, neoplasm",,
127,114,P,S,,,,,,,,,,C,,,cBioPortal,"ccle_broad_2019, mel_mskimpact_2020, msk_met_2021, sarcoma_mskcc_2022","Cutaneous Melanoma, Mixed Cancer Types, Soft Tissue","hg19,19:13050388-13050388","hg19,19:g.13050388C>T",0.176,,,,
128,115,N,,,,,,,,,,,C,,,,,,,,,,,,
129,116,S,,,,,,,,,,,C,,,,,,,,,,,,
130,117,L,S,,,,,,,,,,C,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,19:13050398-13050398, hg38,19:12939584-12939584","hg19,19:g.13050398T>C, hg38,19:g.12939584T>C",0.225,"kidney, thyroid","carcinoma, carcinoma, clear_cell_renal_cell_carcinoma",,
131,118,D,,,,,,,,,,,C,,,,,,,,,,,,
132,119,Q,R,,,,,,,,,,C,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:13050404-13050404, hg38,19:12939590-12939590","hg19,19:g.13050404A>G, hg38,19:g.12939590A>G",,lung,"carcinoma, squamous_cell_carcinoma",,
133,120,T,,,,,,,,,,,C,,,,,,,,,,,,
134,121,D,,,,,,,,,,,C,,,,,,,,,,,,
135,122,M,I,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12939600-12939600","hg38,19:g.12939600G>T",0.309,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
136,122,M,T,,,,,,,,,,C,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:13050413-13050413, hg38,19:12939599-12939599","hg19,19:g.13050413T>C, hg38,19:g.12939599T>C",,kidney,,,
137,122,M,V,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12939598-12939598","hg38,19:g.12939598A>G",0.245,pancreas,"carcinoma, ductal_carcinoma",0.0000119286191430,
138,123,H,,,,,,,,,,,C,,,,,,,,,,,,
139,124,G,,,,,,,,,,,C,,,,,,,,,,,,
140,125,D,,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM",,,,,,,,,,,
141,126,S,L,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,19:13050425-13050425, hg38,19:12939611-12939611","hg19,19:g.13050425C>T, hg38,19:g.12939611C>T",0.630,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
142,127,E,,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,,,,,,,,,,
143,128,Y,C,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM|Y-based sorting signal, 128-131, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:13050431-13050431, hg38,19:12939617-12939617","hg19,19:g.13050431A>G, hg38,19:g.12939617A>G",,endometrium,"carcinoma, endometrioid_carcinoma",,
144,128,Y,H,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM|Y-based sorting signal, 128-131, ELM",,COSMIC,,,"hg38,19:12939616-12939616","hg38,19:g.12939616T>C",,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
145,129,N,I,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM|Y-based sorting signal, 128-131, ELM",,cBioPortal,"ccle_broad_2019, mds_iwg_2022","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,19:13050434-13050434","hg19,19:g.13050434A>T",0.173,,,0.0000119298524675,
146,129,N,S,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM|Y-based sorting signal, 128-131, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:13050434-13050434, hg38,19:12939620-12939620","hg19,19:g.13050434A>G, hg38,19:g.12939620A>G",0.079,large_intestine,"carcinoma, adenocarcinoma",,
147,130,I,,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM|Y-based sorting signal, 128-131, ELM",,,,,,,,,,,
148,131,M,,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM|Y-based sorting signal, 128-131, ELM",,,,,,,,,,,
149,132,F,L,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,"cBioPortal,COSMIC","stad_tcga_pub, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Stomach Adenocarcinoma","hg19,19:13050442-13050442, hg38,19:12939628-12939628","hg19,19:g.13050442T>C, hg38,19:g.12939628T>C",0.880,"endometrium, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,
150,133,G,,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,,,,,,,,,,
151,134,P,L,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050870-13050870","hg19,19:g.13050870C>T",0.824,,,,
152,134,P,T,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,19:13050869-13050869","hg19,19:g.13050869C>A",0.849,,,,
153,135,D,G,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050873-13050873","hg19,19:g.13050873A>G",0.851,,,,
154,135,D,H,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,COSMIC,,,"hg38,19:12940058-12940058","hg38,19:g.12940058G>C",0.841,liver,"other, neoplasm",,
155,135,D,N,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,cBioPortal,"ccle_broad_2019, coad_cptac_2019","Colon Adenocarcinoma, Mixed Cancer Types","hg19,19:13050872-13050872","hg19,19:g.13050872G>A",,,,,
156,136,I,,,,,,,,,,,C,"Atg8 protein family ligands, 125-136, ELM|Atg8 protein family ligands, 126-136, ELM|Atg8 protein family ligands, 127-136, ELM",,,,,,,,,,,
157,137,C,,,,,,,,,,,C,,,,,,,,,,,,
158,138,G,D,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050882-13050882","hg19,19:g.13050882G>A",0.798,,,,
159,139,P,,,,,,,,,,,C,"FHA phosphopeptide ligands, 139-145, ELM",,,,,,,,,,,
160,140,G,,,,,,,,,,,C,"FHA phosphopeptide ligands, 139-145, ELM",,,,,,,,,,,
161,141,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 139-145, ELM",,,,,,,,,,,
162,142,K,,,,,,,Ac,,,,C,"MAPK docking motifs, 142-148, ELM|FHA phosphopeptide ligands, 139-145, ELM",,,,,,,,,,,
163,143,K,,,,Ubq,,,Ac,,,,C,"MAPK docking motifs, 142-148, ELM|FHA phosphopeptide ligands, 139-145, ELM",,,,,,,,,,,
164,144,V,,,,,,,,,,,C,"MAPK docking motifs, 142-148, ELM|FHA phosphopeptide ligands, 139-145, ELM",,,,,,,,,,,
165,145,H,Y,,,,,,,,,,C,"MAPK docking motifs, 142-148, ELM|FHA phosphopeptide ligands, 139-145, ELM",,cBioPortal,"crc_apc_impact_2020, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:13050902-13050902","hg19,19:g.13050902C>T",,,,,
166,146,V,,,,,,,,,,,C,"MAPK docking motifs, 142-148, ELM",,,,,,,,,,,
167,147,I,,,,,,,,,,,C,"MAPK docking motifs, 142-148, ELM",,,,,,,,,,,
168,148,F,,,,,,,,,,,C,"MAPK docking motifs, 142-148, ELM",,,,,,,,,,,
169,149,N,,,,,,,,,,,C,,,,,,,,,,,,
170,150,Y,H,P,,,,,,,,,C,,,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018",Papillary Renal Cell Carcinoma,"hg19,19:13050917-13050917, hg38,19:12940103-12940103","hg19,19:g.13050917T>C, hg38,19:g.12940103T>C",0.370,kidney,"carcinoma, papillary_renal_cell_carcinoma",,
171,151,K,Q,,,Ubq,,,Ac,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13050920-13050920","hg19,19:g.13050920A>C",,,,0.0000198826130525,
172,152,G,,,,,,,,,,,C,,,,,,,,,,,,
173,153,K,,,,Ubq,,,Ac,,,,C,"PCSK cleavage site, 153-157, ELM",,,,,,,,,,,
174,154,N,,,,,,,,,,,C,"PCSK cleavage site, 153-157, ELM",,,,,,,,,,,
175,155,V,,,,,,,,,,,C,"PCSK cleavage site, 153-157, ELM",,,,,,,,,,,
176,156,L,,,,,,,,,,,C,"PCSK cleavage site, 153-157, ELM",,,,,,,,,,,
177,157,I,,,,,,,,,,,C,"PCSK cleavage site, 153-157, ELM",,,,,,,,,,,
178,158,N,D,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940127-12940127","hg38,19:g.12940127A>G",0.320,liver,"carcinoma, hepatocellular_carcinoma",0.0000238587561635,0.0000636739891754
179,159,K,,,,Ubq,,,Ac,,,,C,,,,,,,,,,,,
180,160,D,,,,,,,,,,,C,,,,,,,,,,,,
181,161,I,,,,,,,,,,,C,,,,,,,,,,,,
182,162,R,C,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13050953-13050953","hg19,19:g.13050953C>T",0.311,,,0.0000159062169449,
183,163,C,,,,,,,,,,,C,,,,,,,,,,,,
184,164,K,N,,,,,,,,,,C,,,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13050961-13050961","hg19,19:g.13050961G>T",,,,,
185,165,D,G,,,,,,,,,,C,"Atg8 protein family ligands, 165-176, ELM",,"cBioPortal,COSMIC","mixed_pipseq_2017, prostate_pcbm_swiss_2019, utuc_pdx_msk_2019","Mixed Cancer Types, Prostate, Upper Tract Urothelial Carcinoma","hg19,19:13051058-13051058, hg38,19:12940244-12940244","hg19,19:g.13051058A>G, hg38,19:g.12940244A>G",0.269,"skin, foot","other, atypical_Spitzoid_tumour",0.0003936600844580,0.0001911436763300
186,166,D,N,,,,,,,,,,C,"Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, luad_mskimpact_2021, mixed_impact_subset_2022, msk_met_2021","Bladder Urothelial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,19:13051060-13051060, hg38,19:12940246-12940246","hg19,19:g.13051060G>A, hg38,19:g.12940246G>A",0.465,"urinary_tract, bladder",carcinoma,,
187,167,E,K,,,,,,,,,,C,"Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM",,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,19:13051063-13051063, hg38,19:12940249-12940249","hg19,19:g.13051063G>A, hg38,19:g.12940249G>A",0.193,breast,"carcinoma, carcinoma, ER-PR-positive_carcinoma",,
188,168,F,,,,,,,,,,,C,"Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM",,,,,,,,,,,
189,169,T,,P,,,,,,,,,C,"Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM",,,,,,,,,,,
190,170,H,,,,,,,,,,,C,"Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM",,,,,,,,,,,
191,171,L,,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM",,,,,,,,,,,
192,172,Y,,P,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-175, ELM|Y-based sorting signal, 172-175, ELM",,,,,,,,,,,
193,173,T,A,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-175, ELM|Y-based sorting signal, 172-175, ELM",,cBioPortal,"msk_met_2021, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13051081-13051081","hg19,19:g.13051081A>G",0.706,,,,
194,174,L,,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-175, ELM|Y-based sorting signal, 172-175, ELM",,,,,,,,,,,
195,175,I,S,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-175, ELM|Y-based sorting signal, 172-175, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051088-13051088","hg19,19:g.13051088T>G",0.838,,,,
196,176,V,,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 165-176, ELM|Atg8 protein family ligands, 166-176, ELM|Atg8 protein family ligands, 167-176, ELM|Atg8 protein family ligands, 169-178, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 172-176, ELM",,,,,,,,,,,
197,177,R,G,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 169-178, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051093-13051093","hg19,19:g.13051093C>G",0.331,,,,
198,177,R,Q,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 169-178, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051094-13051094, hg38,19:12940280-12940280","hg19,19:g.13051094G>A, hg38,19:g.12940280G>A",,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0000039763012446,0.0000318613394507
199,177,R,W,,,,,,,,,,C,"FHA phosphopeptide ligands, 171-177, ELM|Atg8 protein family ligands, 169-178, ELM",,cBioPortal,"prad_p1000, prad_tcga",Prostate Adenocarcinoma,"hg19,19:13051093-13051093","hg19,19:g.13051093C>T",0.473,,,0.0000159049520068,
200,178,P,L,,,,,,,,,,C,"Atg8 protein family ligands, 169-178, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:13051097-13051097, hg38,19:12940283-12940283","hg19,19:g.13051097C>T, hg38,19:g.12940283C>T",0.821,skin,malignant_melanoma,,
201,178,P,S,,,,,,,,,,C,"Atg8 protein family ligands, 169-178, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:13051096-13051096, hg38,19:12940282-12940282","hg19,19:g.13051096C>T, hg38,19:g.12940282C>T",0.611,skin,malignant_melanoma,,
202,179,D,G,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM",,cBioPortal,rbl_mskcc_2020,Retinoblastoma,"hg19,19:13051100-13051100","hg19,19:g.13051100A>G",,,,0.0000039762696229,
203,179,D,H,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,19:13051099-13051099, hg38,19:12940285-12940285","hg19,19:g.13051099G>C, hg38,19:g.12940285G>C",0.568,"urinary_tract, bladder",carcinoma,,
204,180,N,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM",,"cBioPortal,COSMIC","msk_impact_2017, tmb_mskcc_2018",Mixed Cancer Types,"hg19,19:13051104-13051104, hg38,19:12940290-12940290","hg19,19:g.13051104C>A, hg38,19:g.12940290C>A",0.367,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
205,181,T,,P,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM",,,,,,,,,,,
206,182,Y,H,P,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM|Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13051108-13051108","hg19,19:g.13051108T>C",0.760,,,,
207,183,E,D,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM|Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,cBioPortal,"msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13051113-13051113","hg19,19:g.13051113G>T",0.295,,,,
208,184,V,L,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM|Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,cBioPortal,lung_msk_mind_2020,Lung,"hg19,19:13051114-13051114","hg19,19:g.13051114G>T",,,,,
209,184,V,M,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM|Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051114-13051114","hg19,19:g.13051114G>A",0.492,,,,
210,185,K,E,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM|Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,COSMIC,,,"hg38,19:12940303-12940303","hg38,19:g.12940303A>G",,stomach,"carcinoma, adenocarcinoma",,
211,185,K,N,,,,,,,,,,C,"FHA phosphopeptide ligands, 179-185, ELM|Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051119-13051119","hg19,19:g.13051119G>C",0.257,,,,
212,186,I,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 182-186, ELM",,,,,,,,,,,
213,187,D,,,,,,,,,,,C,,,,,,,,,,,,
214,188,N,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:13051126-13051126, hg38,19:12940312-12940312","hg19,19:g.13051126A>G, hg38,19:g.12940312A>G",0.367,"large_intestine, colon","carcinoma, adenocarcinoma",,
215,188,N,S,,,,,,,,,,C,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13051127-13051127, hg38,19:12940313-12940313","hg19,19:g.13051127A>G, hg38,19:g.12940313A>G",0.410,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039762063810,
216,189,S,,,,,,,,,,,C,,,,,,,,,,,,
217,190,Q,,,,,,,,,,,C,,,,,,,,,,,,
218,191,V,M,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051135-13051135","hg19,19:g.13051135G>A",0.343,,,,
219,192,E,,,,,,,,,,,C,,,,,,,,,,,,
220,193,S,,,,,,,,,,,C,,,,,,,,,,,,
221,194,G,D,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940331-12940331","hg38,19:g.12940331G>A",,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",,
222,195,S,F,P,,,,,,,,,C,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:13051148-13051148","hg19,19:g.13051148C>T",,,,,
223,196,L,,,,,,,,,,,C,,,,,,,,,,,,
224,197,E,Q,,,,,,,,,,C,"Atg8 protein family ligands, 197-208, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 197-202, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051153-13051153","hg19,19:g.13051153G>C",0.334,,,,
225,198,D,,,,,,,,,,,C,"Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 197-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 198-202, ELM",,,,,,,,,,,
226,199,D,N,,,,,,,,,,C,"Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 197-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 198-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 199-202, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021, ucec_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13051159-13051159, hg38,19:12940345-12940345","hg19,19:g.13051159G>A, hg38,19:g.12940345G>A",0.421,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000119288088687,0.0000318471337580
227,200,W,,,,,,,,,,,C,"Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 197-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 198-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 199-202, ELM",,,,,,,,,,,
228,201,D,A,,,,,,,,,,C,"Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 197-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 198-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 199-202, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051166-13051166","hg19,19:g.13051166A>C",,,,,
229,202,F,,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 202-205, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 197-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 198-202, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 199-202, ELM",,,,,,,,,,,
230,203,L,,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 202-205, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,,,,,,,,,,
231,204,P,S,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 202-205, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:13051174-13051174, hg38,19:12940360-12940360","hg19,19:g.13051174C>T, hg38,19:g.12940360C>T",0.482,stomach,"carcinoma, adenocarcinoma",0.0000000000000000,
232,205,P,L,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 202-205, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051178-13051178","hg19,19:g.13051178C>T",0.366,,,,
233,206,K,N,,,Ubq,,,Ac,,,,C,"PCSK cleavage site, 206-210, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13051182-13051182","hg19,19:g.13051182G>T",0.373,,,,
234,207,K,E,,,Ubq,,,Ac,,,,C,"PCSK cleavage site, 206-210, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,cBioPortal,gbc_mskcc_2022,Gallbladder Cancer,"hg19,19:13051183-13051183","hg19,19:g.13051183A>G",0.260,,,,
235,207,K,N,,,Ubq,,,Ac,,,,C,"PCSK cleavage site, 206-210, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,"cBioPortal,COSMIC",brca_smc_2018,Invasive Breast Carcinoma,"hg19,19:13051185-13051185, hg38,19:12940371-12940371","hg19,19:g.13051185G>C, hg38,19:g.12940371G>T",0.230,stomach,carcinoma,,
236,208,I,,,,,,,,,,,C,"PCSK cleavage site, 206-210, ELM|Atg8 protein family ligands, 197-208, ELM|Atg8 protein family ligands, 198-208, ELM|Atg8 protein family ligands, 199-208, ELM",,,,,,,,,,,
237,209,K,,,,Ubq,,,Ac,,,,C,"PCSK cleavage site, 206-210, ELM",,,,,,,,,,,
238,210,D,N,,,,,,,,,,C,"PCSK cleavage site, 206-210, ELM",,cBioPortal,"breast_ink4_msk_2021, msk_met_2021, nepc_wcm_2016","Breast, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13051192-13051192","hg19,19:g.13051192G>A",0.448,,,,
239,211,P,S,,,,,,,,,,C,"USP7 binding motif, 211-215, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13051195-13051195","hg19,19:g.13051195C>T",0.513,,,0.0000039765226105,
240,212,D,G,,,,,,,,,,C,"USP7 binding motif, 211-215, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13051199-13051199","hg19,19:g.13051199A>G",0.076,,,,
241,213,A,,,,,,,,,,,C,"USP7 binding motif, 211-215, ELM",,,,,,,,,,,
242,214,S,L,P,,,,,,,,,C,"USP7 binding motif, 211-215, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:13051205-13051205, hg38,19:12940391-12940391","hg19,19:g.13051205C>T, hg38,19:g.12940391C>T",,lung,"carcinoma, adenocarcinoma",,
243,215,K,,,,,,,,,,,C,"USP7 binding motif, 211-215, ELM",,,,,,,,,,,
244,216,P,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13051211-13051211, hg38,19:12940397-12940397","hg19,19:g.13051211C>T, hg38,19:g.12940397C>T",0.799,"upper_aerodigestive_tract, head_neck",carcinoma,0.0000516984943808,0.0000955779278705
245,217,E,D,,,,,,,,,,C,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:13051215-13051215","hg19,19:g.13051215A>C",,,,,
246,218,D,V,,,,,,,,,,C,,,cBioPortal,"breast_ink4_msk_2021, msk_met_2021","Breast, Mixed Cancer Types","hg19,19:13051217-13051217","hg19,19:g.13051217A>T",0.692,,,,
247,219,W,L,,,,,,,,,,C,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018",Bladder Urothelial Carcinoma,"hg19,19:13051220-13051220, hg38,19:12940406-12940406","hg19,19:g.13051220G>T, hg38,19:g.12940406G>T",0.789,"placenta, urinary_tract, bladder","carcinoma, choriocarcinoma",,
248,220,D,N,,,,,,,,,,C,,,cBioPortal,"glioma_msk_2018, msk_access_2021, msk_met_2021, ucec_ccr_msk_2022","Diffuse Glioma, Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13051222-13051222","hg19,19:g.13051222G>A",0.459,,,,
249,221,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020",Bladder Urothelial Carcinoma,"hg19,19:13051225-13051225, hg38,19:12940411-12940411","hg19,19:g.13051225G>A, hg38,19:g.12940411G>A",0.396,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000039771235851,
250,222,R,Q,,Me,,,,,,,,C,,,COSMIC,,,"hg38,19:12940415-12940415","hg38,19:g.12940415G>A",0.289,stomach,carcinoma,0.0000238648296051,0.0000637145587767
251,222,R,W,,Me,,,,,,,,C,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13051228-13051228","hg19,19:g.13051228C>T",0.407,,,0.0000159097598422,
252,223,A,T,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:13051231-13051231, hg38,19:12940417-12940417","hg19,19:g.13051231G>A, hg38,19:g.12940417G>A",0.093,"large_intestine, colon","carcinoma, adenocarcinoma",,
253,224,K,N,,,,,,,,,,C,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,19:13051236-13051236, hg38,19:12940422-12940422","hg19,19:g.13051236G>C, hg38,19:g.12940422G>C",0.262,lung,"carcinoma, squamous_cell_carcinoma",,
254,225,I,,,,,,,,,,,C,,,,,,,,,,,,
255,226,D,H,,,,,,,,,,C,,,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13051240-13051240","hg19,19:g.13051240G>C",0.325,,,,0.0000318511912346
256,226,D,N,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051240-13051240","hg19,19:g.13051240G>A",0.299,,,0.0000159120382525,0.0000318511912346
257,227,D,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940430-12940430","hg38,19:g.12940430A>G",0.850,breast,"carcinoma, ductal_carcinoma",,
258,228,P,S,,,,,,,,,,C,"USP7 binding motif, 228-232, ELM",,COSMIC,,,"hg38,19:12940432-12940432","hg38,19:g.12940432C>T",,lung,"carcinoma, non_small_cell_carcinoma",0.0011656588160407,0.0003186133945071
259,229,T,,P,,,,,,,,,C,"USP7 binding motif, 228-232, ELM",,,,,,,,,,,
260,230,D,,,,,,,,,,,C,"USP7 binding motif, 228-232, ELM",,,,,,,,,,,
261,231,S,,P,,,,,,,,,C,"USP7 binding motif, 228-232, ELM",,,,,,,,,,,
262,232,K,,,,,,,,,,,C,"USP7 binding motif, 228-232, ELM",,,,,,,,,,,
263,233,P,,,,,,,,,,,C,,,,,,,,,,,,
264,234,E,G,,,,,,,,,,C,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13051265-13051265","hg19,19:g.13051265A>G",0.446,,,,
265,234,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, msk_met_2021, nsclc_ctdx_msk_2022, nsclc_tcga_broad_2016, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,19:13051264-13051264, hg38,19:12940450-12940450","hg19,19:g.13051264G>A, hg38,19:g.12940450G>A",0.516,"endometrium, lung","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,
266,235,D,,,,,,,,,,,C,,,,,,,,,,,,
267,236,W,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:13051359-13051359, hg38,19:12940545-12940545","hg19,19:g.13051359G>T, hg38,19:g.12940545G>T",0.603,skin,malignant_melanoma,,
268,237,D,,,,,,,,,,,C,,,,,,,,,,,,
269,238,K,,,Me,,,,Ac,,,,C,,,,,,,,,,,,
270,239,P,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:13051368-13051368, hg38,19:12940554-12940554","hg19,19:g.13051368C>T, hg38,19:g.12940554C>T",0.377,skin,malignant_melanoma,,
271,239,P,S,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940553-12940553","hg38,19:g.12940553C>T",0.290,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, mantle_cell_lymphoma",,
272,240,E,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:13051372-13051372, hg38,19:12940558-12940558","hg19,19:g.13051372G>T, hg38,19:g.12940558G>T",0.243,"large_intestine, colon","carcinoma, adenocarcinoma",,
273,241,H,,,,,,,,,,,C,,,,,,,,,,,,
274,242,I,,,,,,,,,,,C,,,,,,,,,,,,
275,243,P,H,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051380-13051380","hg19,19:g.13051380C>A",0.342,,,,
276,243,P,L,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940566-12940566","hg38,19:g.12940566C>T",0.254,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma, non_keratinizing",0.0001431923948928,0.0000955474871011
277,243,P,S,,,,,,,,,,C,,,"cBioPortal,COSMIC","ccle_broad_2019, msk_impact_2017",Mixed Cancer Types,"hg19,19:13051379-13051379, hg38,19:12940565-12940565","hg19,19:g.13051379C>T, hg38,19:g.12940565C>T",0.281,,"carcinoma, of_unknown_primary",,
278,243,P,Y,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051379-13051380","hg19,19:g.13051379_13051380delinsTA",,,,,
279,244,D,G,,,,,,,,,,C,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,19:13051383-13051383, hg38,19:12940569-12940569","hg19,19:g.13051383A>G, hg38,19:g.12940569A>G",,"large_intestine, colon",carcinoma,,
280,244,D,N,,,,,,,,,,C,,,cBioPortal,brca_mbcproject_2022,Invasive Breast Carcinoma,"hg19,19:13051382-13051382","hg19,19:g.13051382G>A",0.581,,,,
281,245,P,L,,,,,,,,,,C,,,cBioPortal,gist_msk_2022,Gastrointestinal Stromal Tumor,"hg19,19:13051386-13051386","hg19,19:g.13051386C>T",0.356,,,0.0000079550697660,
282,246,D,,,,,,,,,,,C,,,,,,,,,,,,
283,247,A,,,,,,,,,,,C,,,,,,,,,,,,
284,248,K,N,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,19:13051396-13051396, hg38,19:12940582-12940582","hg19,19:g.13051396G>C, hg38,19:g.12940582G>C",0.126,lung,carcinoma,,
285,249,K,,,,,,,,,,,C,,,,,,,,,,,,
286,250,P,,,,,,,,,,,C,,,,,,,,,,,,
287,251,E,D,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940591-12940591","hg38,19:g.12940591G>T",0.066,thyroid,"carcinoma, anaplastic_carcinoma, carcinoma, follicular_carcinoma",,
288,251,E,K,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940589-12940589","hg38,19:g.12940589G>A",0.251,prostate,"carcinoma, adenocarcinoma",0.0000119322249622,
289,252,D,G,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:13051407-13051407, hg38,19:12940593-12940593","hg19,19:g.13051407A>G, hg38,19:g.12940593A>G",0.381,large_intestine,"carcinoma, adenocarcinoma",,
290,252,D,N,,,,,,,,,,C,,,cBioPortal,glioma_msk_2018,Diffuse Glioma,"hg19,19:13051406-13051406","hg19,19:g.13051406G>A",0.427,,,,
291,253,W,L,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051410-13051410","hg19,19:g.13051410G>T",0.667,,,,
292,254,D,E,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940600-12940600","hg38,19:g.12940600T>G",0.378,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
293,255,E,K,,,,,,,,,,C,"Caspase cleavage motif, 255-259, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, cfdna_msk_2019","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,19:13051415-13051415, hg38,19:12940601-12940601","hg19,19:g.13051415G>A, hg38,19:g.12940601G>A",0.288,"urinary_tract, bladder",carcinoma,,
294,256,E,K,,,,,,,,,,C,"Caspase cleavage motif, 255-259, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,19:13051418-13051418, hg38,19:12940604-12940604","hg19,19:g.13051418G>A, hg38,19:g.12940604G>A",,"urinary_tract, bladder",carcinoma,0.0000039771868562,
295,257,M,V,,,,,,,,,,C,"Caspase cleavage motif, 255-259, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:13051421-13051421, hg38,19:12940607-12940607","hg19,19:g.13051421A>G, hg38,19:g.12940607A>G",0.221,large_intestine,"carcinoma, adenocarcinoma",,
296,258,D,,,,,,,,,,,C,"Caspase cleavage motif, 255-259, ELM",,,,,,,,,,,
297,259,G,R,,,,,,,,,,C,"Caspase cleavage motif, 255-259, ELM",,COSMIC,,,"hg38,19:12940613-12940613","hg38,19:g.12940613G>A",0.928,"large_intestine, colon, skin, mucosal, nasopharynx","carcinoma, adenocarcinoma, malignant_melanoma",,
298,260,E,D,,,,,,,,,,C,,,cBioPortal,luad_cptac_2020,Lung Adenocarcinoma,"hg19,19:13051432-13051432","hg19,19:g.13051432G>T",0.281,,,,
299,260,E,V,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051431-13051431","hg19,19:g.13051431A>T",0.548,,,,
300,261,W,C,,,,,,,,,,C,,,"cBioPortal,COSMIC",hnsc_tcga_pan_can_atlas_2018,Head and Neck Squamous Cell Carcinoma,"hg19,19:13051435-13051435, hg38,19:12940621-12940621","hg19,19:g.13051435G>T, hg38,19:g.12940621G>T",,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
301,262,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,19:13051436-13051436, hg38,19:12940622-12940622","hg19,19:g.13051436G>A, hg38,19:g.12940622G>A",0.236,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
302,263,P,L,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051440-13051440","hg19,19:g.13051440C>T",0.298,,,,
303,264,P,Q,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940629-12940629","hg38,19:g.12940629C>A",0.654,placenta,choriocarcinoma,,
304,264,P,S,,,,,,,,,,C,,,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13051442-13051442","hg19,19:g.13051442C>T",0.453,,,0.0000079544369850,
305,265,V,,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,,,,,,,,,,
306,266,I,N,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,cBioPortal,dlbc_broad_2012,"Diffuse Large B-Cell Lymphoma, NOS","hg19,19:13051449-13051449","hg19,19:g.13051449T>A",,,,,
307,267,Q,H,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,19:13051453-13051453, hg38,19:12940639-12940639","hg19,19:g.13051453G>T, hg38,19:g.12940639G>T",0.033,endometrium,"carcinoma, endometrioid_carcinoma",,
308,267,Q,K,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,cBioPortal,dlbc_broad_2012,"Diffuse Large B-Cell Lymphoma, NOS","hg19,19:13051451-13051451","hg19,19:g.13051451C>A",0.040,,,,
309,267,Q,R,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051452-13051452, hg38,19:12940638-12940638","hg19,19:g.13051452A>G, hg38,19:g.12940638A>G",,lung,"carcinoma, large_cell_carcinoma",,
310,268,N,,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,,,,,,,,,,
311,269,P,S,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,19:13051457-13051457","hg19,19:g.13051457C>T",0.784,,,,
312,270,E,A,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,COSMIC,,,"hg38,19:12940647-12940647","hg38,19:g.12940647A>C",0.092,stomach,carcinoma,,
313,270,E,D,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051462-13051462","hg19,19:g.13051462G>T",0.078,,,,
314,270,E,K,,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,COSMIC,,,"hg38,19:12940646-12940646","hg38,19:g.12940646G>A",0.099,"biliary_tract, gallbladder","carcinoma, small_cell_carcinoma",,
315,271,Y,,P,,,,,,,,,C,"PTB ligand, 265-272, ELM|PTB ligand, 265-271, ELM",,,,,,,,,,,
316,272,K,,,,,,,,,,,C,"USP7 binding motif, 272-276, ELM|PTB ligand, 265-272, ELM",,,,,,,,,,,
317,273,G,,,,,,,,,,,C,"USP7 binding motif, 272-276, ELM",,,,,,,,,,,
318,274,E,,,,,,,,,,,C,"USP7 binding motif, 272-276, ELM",,,,,,,,,,,
319,275,W,,,,,,,,,,,C,"USP7 binding motif, 272-276, ELM",,,,,,,,,,,
320,276,K,,,,,,,,,,,C,"USP7 binding motif, 272-276, ELM",,,,,,,,,,,
321,277,P,L,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051571-13051571","hg19,19:g.13051571C>T",,,,,
322,278,R,Q,,,,,,,,,,C,,,cBioPortal,dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,19:13051574-13051574","hg19,19:g.13051574G>A",0.072,,,0.0000119289037337,0.0000637348629700
323,279,Q,H,,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051578-13051578","hg19,19:g.13051578G>T",0.265,,,,
324,279,Q,R,,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13051577-13051577","hg19,19:g.13051577A>G",,,,0.0000119289037337,
325,280,I,,,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,,,,,,,,,,
326,281,D,,,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,,,,,,,,,,
327,282,N,S,,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,COSMIC,,,"hg38,19:12940772-12940772","hg38,19:g.12940772A>G",0.764,stomach,carcinoma,,
328,283,P,,,,,,,,,,,D,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,,,,,,,,,,
329,284,D,,,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,,,,,,,,,,
330,285,Y,,P,,,,,,,,,C,"PTB ligand, 279-286, ELM|PTB ligand, 279-285, ELM",,,,,,,,,,,
331,286,K,M,,,,,,Ac,,,,C,"PTB ligand, 279-286, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13051598-13051598","hg19,19:g.13051598A>T",0.378,,,,
332,287,G,,,,,,,,,,,C,,,,,,,,,,,,
333,288,T,,,,,,,,,,,C,,,,,,,,,,,,
334,289,W,,,,,,,,,,,C,,,,,,,,,,,,
335,290,I,,,,,,,,,,,C,,,,,,,,,,,,
336,291,H,,,,,,,,,,,C,,,,,,,,,,,,
337,292,P,,,,,,,,,,,C,,,,,,,,,,,,
338,293,E,K,,,,,,,,,,C,"PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,19:13051618-13051618","hg19,19:g.13051618G>A",0.201,,,,
339,294,I,M,,,,,,,,,,C,"PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13051623-13051623","hg19,19:g.13051623T>G",0.425,,,,
340,295,D,N,,,,,,,,,,C,"PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13051624-13051624","hg19,19:g.13051624G>A",0.316,,,0.0000079525392458,
341,296,N,,,,,,,,,,,C,"PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,,,,,,,,,,
342,297,P,L,,,,,,,,,,C,"WW domain ligands, 297-302, ELM|PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,"cBioPortal,COSMIC","cscc_hgsc_bcm_2014, mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types","hg19,19:13051631-13051631, hg19,19:13051631-13051632, hg38,19:12940817-12940818","hg19,19:g.13051631C>T, hg19,19:g.13051631_13051632delinsTT, hg38,19:g.12940817_12940818delinsTT",0.737,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
343,298,E,D,,,,,,,,,,C,"WW domain ligands, 297-302, ELM|PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13051635-13051635","hg19,19:g.13051635G>T",0.127,,,,
344,298,E,G,,,,,,,,,,C,"WW domain ligands, 297-302, ELM|PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13051634-13051634, hg38,19:12940820-12940820","hg19,19:g.13051634A>G, hg38,19:g.12940820A>G",0.308,endometrium,"carcinoma, endometrioid_carcinoma",,
345,299,Y,,P,,,,,,,,,C,"WW domain ligands, 297-302, ELM|PTB ligand, 293-300, ELM|PTB ligand, 293-299, ELM",,,,,,,,,,,
346,300,S,F,P,,,,,,,,,C,"WW domain ligands, 297-302, ELM|PTB ligand, 293-300, ELM",,COSMIC,,,"hg38,19:12940826-12940826","hg38,19:g.12940826C>T",0.141,urinary_tract,"carcinoma, transitional_cell_carcinoma",,
347,300,S,Y,P,,,,,,,,,C,"WW domain ligands, 297-302, ELM|PTB ligand, 293-300, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:13051640-13051640, hg38,19:12940826-12940826","hg19,19:g.13051640C>A, hg38,19:g.12940826C>A",0.134,endometrium,"carcinoma, endometrioid_carcinoma",,
348,301,P,,,,,,,,,,,C,"USP7 binding motif, 301-305, ELM|WW domain ligands, 297-302, ELM",,,,,,,,,,,
349,302,D,N,,,,,,,,,,C,"USP7 binding motif, 301-305, ELM|WW domain ligands, 297-302, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, lung_msk_mind_2020, msk_impact_2017","Lung, Mixed Cancer Types","hg19,19:13051645-13051645, hg38,19:12940831-12940831","hg19,19:g.13051645G>A, hg38,19:g.12940831G>A",0.389,"cervix, haematopoietic_and_lymphoid_tissue","carcinoma, endocervical_adenocarcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0000318099040136,
350,303,P,L,,,,,,,,,,C,"USP7 binding motif, 301-305, ELM",,cBioPortal,"aml_ohsu_2018, mds_mskcc_2020, mixed_allen_2018","Acute Myeloid Leukemia, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,19:13051649-13051649","hg19,19:g.13051649C>T",0.039,,,,
351,303,P,R,,,,,,,,,,C,"USP7 binding motif, 301-305, ELM",,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13051649-13051649","hg19,19:g.13051649C>G",0.104,,,0.0000039762380017,
352,304,S,,,,,,,,,,,C,"USP7 binding motif, 301-305, ELM",,,,,,,,,,,
353,305,I,M,,,,,,,,,,C,"USP7 binding motif, 301-305, ELM",,cBioPortal,"luad_mskimpact_2021, msk_access_2021, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,19:13051656-13051656","hg19,19:g.13051656C>G",0.106,,,,
354,306,Y,,,,,,,,,,,C,,,,,,,,,,,,
355,307,A,V,,,,,,,,,,C,,,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13051661-13051661","hg19,19:g.13051661C>T",0.048,,,0.0000159049520068,
356,308,Y,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 308-311, ELM|Y-based sorting signal, 308-311, ELM",,,,,,,,,,,
357,309,D,N,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 308-311, ELM|Y-based sorting signal, 308-311, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,19:13051666-13051666, hg38,19:12940852-12940852","hg19,19:g.13051666G>A, hg38,19:g.12940852G>A",0.134,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",0.0000039762380017,
358,309,D,Y,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 308-311, ELM|Y-based sorting signal, 308-311, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,19:13051666-13051666, hg38,19:12940852-12940852","hg19,19:g.13051666G>T, hg38,19:g.12940852G>T",,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
359,310,N,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 308-311, ELM|Y-based sorting signal, 308-311, ELM",,,,,,,,,,,
360,311,F,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 308-311, ELM|Y-based sorting signal, 308-311, ELM",,,,,,,,,,,
361,312,G,,,,,,,,,,,C,,,,,,,,,,,,
362,313,V,E,,,,,,,,,,C,,,cBioPortal,angs_painter_2020,Angiosarcoma,"hg19,19:13051679-13051679","hg19,19:g.13051679T>A",0.429,,,,
363,313,V,M,,,,,,,,,,C,,,"cBioPortal,COSMIC","msk_met_2021, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13051678-13051678, hg38,19:12940864-12940864","hg19,19:g.13051678G>A, hg38,19:g.12940864G>A",,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039762380017,
364,314,L,,,,,,,,,,,C,,,,,,,,,,,,
365,315,G,A,,,,,,,,,,C,,,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,19:13051685-13051685, hg38,19:12940871-12940871","hg19,19:g.13051685G>C, hg38,19:g.12940871G>C",0.543,breast,"carcinoma, ER-PR-positive_carcinoma",,
366,316,L,,,,,,,,,,,C,,,,,,,,,,,,
367,317,D,,,,,,,,,,,C,,,,,,,,,,,,
368,318,L,F,,,,,,,,,,C,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13051693-13051693","hg19,19:g.13051693C>T",0.397,,,,
369,319,W,,,,,,,,,,,C,,,,,,,,,,,,
370,320,Q,K,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12940885-12940885","hg38,19:g.12940885C>A",,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
371,321,V,A,,,,,,,,,,C,,,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13054352-13054352","hg19,19:g.13054352T>C",0.587,,,,
372,322,K,,,,,,,,,,,C,,,,,,,,,,,,
373,323,S,C,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:13054358-13054358","hg19,19:g.13054358C>G",0.500,,,,
374,323,S,F,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,19:13054358-13054358, hg38,19:12943544-12943544","hg19,19:g.13054358C>T, hg38,19:g.12943544C>T",0.584,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
375,324,G,D,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM",,cBioPortal,"msk_met_2021, nsclc_ctdx_msk_2022","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,19:13054361-13054361","hg19,19:g.13054361G>A",0.386,,,,
376,325,T,I,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM|Atg8 protein family ligands, 325-332, ELM",,"cBioPortal,COSMIC","desm_broad_2015, ucs_jhu_2014","Desmoplastic Melanoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,19:13054364-13054364, hg38,19:12943550-12943550","hg19,19:g.13054364C>T, hg38,19:g.12943550C>T",0.347,"skin, trunk","malignant_melanoma, desmoplastic",,
377,325,T,N,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM|Atg8 protein family ligands, 325-332, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,19:13054364-13054365",,,,,,
378,326,I,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM|Atg8 protein family ligands, 325-332, ELM",,"cBioPortal,COSMIC","cfdna_msk_2019, msk_impact_2017, msk_met_2021, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021, prad_su2c_2019","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13054366-13054366, hg38,19:12943552-12943552","hg19,19:g.13054366A>G, hg38,19:g.12943552A>G",0.183,prostate,"carcinoma, adenocarcinoma",0.0000039767756303,
379,327,F,,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM|Atg8 protein family ligands, 325-332, ELM",,,,,,,,,,,
380,328,D,,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM|Atg8 protein family ligands, 325-332, ELM",,,,,,,,,,,
381,329,N,,,,,,,,,,,C,"FHA phosphopeptide ligands, 323-329, ELM|Atg8 protein family ligands, 325-332, ELM",,,,,,,,,,,
382,330,F,V,,,,,,,,,,C,"Atg8 protein family ligands, 325-332, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:13054378-13054378, hg38,19:12943564-12943564","hg19,19:g.13054378T>G, hg38,19:g.12943564T>G",0.251,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
383,331,L,,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM|Atg8 protein family ligands, 325-332, ELM",,,,,,,,,,,
384,332,I,,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM|Atg8 protein family ligands, 325-332, ELM",,,,,,,,,,,
385,333,T,A,P,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,"egc_mskcc_2020, msk_met_2021","Esophagus/Stomach, Mixed Cancer Types","hg19,19:13054387-13054387","hg19,19:g.13054387A>G",0.282,,,,
386,334,N,D,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13054390-13054390","hg19,19:g.13054390A>G",0.085,,,,
387,334,N,S,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,"msk_met_2021, nepc_wcm_2016, prad_p1000","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:13054391-13054391","hg19,19:g.13054391A>G",0.178,,,,
388,335,D,H,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,"blca_bcan_hcrn_2022, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,19:13054393-13054393","hg19,19:g.13054393G>C",0.607,,,0.0000278374294122,
389,335,D,N,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,"cBioPortal,COSMIC","mds_iwg_2022, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Myelodysplastic Syndromes","hg19,19:13054393-13054393, hg38,19:12943579-12943579","hg19,19:g.13054393G>A, hg38,19:g.12943579G>A",0.306,skin,malignant_melanoma,0.0001590710252128,0.0002550695064405
390,336,E,A,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13054397-13054397","hg19,19:g.13054397A>C",0.079,,,,
391,336,E,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,brca_cptac_2020,Invasive Breast Carcinoma,"hg19,19:13054396-13054396","hg19,19:g.13054396G>A",,,,,
392,337,A,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 331-337, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13054400-13054400","hg19,19:g.13054400C>T",0.017,,,0.0000039766174892,
393,338,Y,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 338-342, ELM",,,,,,,,,,,
394,339,A,T,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 338-342, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13054405-13054405","hg19,19:g.13054405G>A",0.426,,,0.0000039768072601,
395,340,E,K,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 338-342, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, msk_met_2021, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,19:13054408-13054408, hg38,19:12943594-12943594","hg19,19:g.13054408G>A, hg38,19:g.12943594G>A",0.179,lung,"carcinoma, squamous_cell_carcinoma",,
396,341,E,G,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 338-342, ELM",,"cBioPortal,COSMIC",stad_tcga_pub,Stomach Adenocarcinoma,"hg19,19:13054412-13054412, hg38,19:12943598-12943598","hg19,19:g.13054412A>G, hg38,19:g.12943598A>G",0.179,stomach,"carcinoma, adenocarcinoma",,
397,341,E,K,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 338-342, ELM",,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,19:13054411-13054411","hg19,19:g.13054411G>A",0.070,,,,
398,342,F,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 338-342, ELM",,,,,,,,,,,
399,343,G,D,,,,,,,,,,C,,,cBioPortal,"coadread_tcga, coadread_tcga_pub, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:13054418-13054418","hg19,19:g.13054418G>A",0.419,,,,
400,343,G,V,,,,,,,,,,C,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,19:13054418-13054418, hg38,19:12943604-12943604","hg19,19:g.13054418G>T, hg38,19:g.12943604G>T",,thyroid,"carcinoma, anaplastic_carcinoma",,
401,344,N,S,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,COSMIC,,,,,,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myeloproliferative_neoplasm",,
402,345,E,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,"cBioPortal,COSMIC","coadread_mskresistance_2022, esca_tcga, esca_tcga_pan_can_atlas_2018, stes_tcga_pub, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,19:13054423-13054423, hg38,19:12943609-12943609","hg19,19:g.13054423G>A, hg38,19:g.12943609G>A",,endometrium,"carcinoma, endometrioid_carcinoma",0.0000159077351362,
403,346,T,M,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,cBioPortal,lgg_tcga_pan_can_atlas_2018,Diffuse Glioma,"hg19,19:13054427-13054427","hg19,19:g.13054427C>T",,,,0.0000159076086092,0.0000318958918091
404,347,W,L,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:13054430-13054430, hg38,19:12943616-12943616","hg19,19:g.13054430G>T, hg38,19:g.12943616G>T",0.312,skin,"carcinoma, basal_cell_carcinoma",,
405,348,G,D,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13054433-13054433","hg19,19:g.13054433G>A",,,,0.0000039769970491,
406,349,V,I,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,cBioPortal,"mpcproject_broad_2021, msk_met_2021","Mixed Cancer Types, Prostate","hg19,19:13054435-13054435","hg19,19:g.13054435G>A",0.034,,,0.0000874946310113,0.0002869531947456
407,350,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 344-350, ELM",,,,,,,,,,,
408,351,K,,,,Ubq,,,,,,,C,"USP7 binding motif, 351-355, ELM",,,,,,,,,,,
409,352,A,,,,,,,,,,,C,"USP7 binding motif, 351-355, ELM",,,,,,,,,,,
410,353,A,,,,,,,,,,,C,"USP7 binding motif, 351-355, ELM",,,,,,,,,,,
411,354,E,D,,,,,,,,,,C,"USP7 binding motif, 351-355, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:13054535-13054535, hg38,19:12943721-12943721","hg19,19:g.13054535G>T, hg38,19:g.12943721G>T",0.185,large_intestine,"carcinoma, adenocarcinoma",,
412,355,K,,,,,,,,,,,C,"PCSK cleavage site, 355-359, ELM|USP7 binding motif, 351-355, ELM",,,,,,,,,,,
413,356,Q,,,,,,,,,,,C,"PCSK cleavage site, 355-359, ELM",,,,,,,,,,,
414,357,M,I,,,,,,,,,,C,"PCSK cleavage site, 355-359, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_access_2021, msk_impact_2017, msk_met_2021, pog570_bcgsc_2020","Lung Adenocarcinoma, Mixed Cancer Types","hg19,19:13054544-13054544, hg38,19:12943730-12943730","hg19,19:g.13054544G>A, hg38,19:g.12943730G>A",0.080,lung,"carcinoma, adenocarcinoma",,
415,358,K,R,,,,,,,,,,C,"PCSK cleavage site, 355-359, ELM",,COSMIC,,,"hg38,19:12943732-12943732","hg38,19:g.12943732A>G",0.124,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
416,359,D,V,,,,,,,,,,C,"PCSK cleavage site, 355-359, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,19:13054549-13054549, hg38,19:12943735-12943735","hg19,19:g.13054549A>T, hg38,19:g.12943735A>T",0.122,lung,"carcinoma, adenocarcinoma",,
417,360,K,,,Me,,,,,,,,C,,,,,,,,,,,,
418,361,Q,,,,,,,,,,,C,,,,,,,,,,,,
419,362,D,,,,,,,,,,,C,,,,,,,,,,,,
420,363,E,K,,,,,,,,,,C,,,cBioPortal,"brca_mbcproject_2022, msk_met_2021","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,19:13054560-13054560","hg19,19:g.13054560G>A",,,,0.0000121663381755,0.0000318694626809
421,364,E,,,,,,,,,,,C,,,,,,,,,,,,
422,365,Q,E,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943752-12943752","hg38,19:g.12943752C>G",0.034,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
423,365,Q,L,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943753-12943753","hg38,19:g.12943753A>T",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
424,366,R,,,Me,,,,,,,,C,,,,,,,,,,,,
425,367,L,F,,,,,,,,,,C,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:13054572-13054572","hg19,19:g.13054572C>T",0.066,,,,
426,367,L,I,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943758-12943758","hg38,19:g.12943758C>A",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
427,368,K,E,,,,,,,,,,C,,,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13054575-13054575","hg19,19:g.13054575A>G",0.046,,,0.0000041951235883,
428,368,K,M,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943762-12943762","hg38,19:g.12943762A>T",0.068,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
429,368,K,R,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943762-12943762","hg38,19:g.12943762A>G",0.032,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
430,369,E,D,,,,,,,,,,C,,,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,19:13054580-13054580","hg19,19:g.13054580G>C",,,,,
431,369,E,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943765-12943765","hg38,19:g.12943765A>G",0.060,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
432,370,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13054581-13054581, hg38,19:12943767-12943767","hg19,19:g.13054581G>A, hg38,19:g.12943767G>A",0.048,"skin, trunk","malignant_melanoma, superficial_spreading",,
433,371,E,D,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943772-12943772","hg38,19:g.12943772A>C",0.170,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
434,371,E,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943771-12943771","hg38,19:g.12943771A>G",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
435,371,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13054584-13054584, hg38,19:12943770-12943770","hg19,19:g.13054584G>A, hg38,19:g.12943770G>A",0.073,endometrium,"carcinoma, endometrioid_carcinoma",,
436,372,E,,,,,,,,,,,C,,,,,,,,,,,,
437,373,D,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943777-12943777","hg38,19:g.12943777A>G",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
438,374,K,N,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943781-12943781","hg38,19:g.12943781G>T",0.099,thyroid,carcinoma,,
439,374,K,Q,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943779-12943779","hg38,19:g.12943779A>C",0.126,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
440,374,K,R,,,,,,,,,,C,,,"cBioPortal,COSMIC","egc_msk_2017, egc_mskcc_2020, msk_impact_2017, msk_met_2021","Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,19:13054594-13054594, hg38,19:12943780-12943780","hg19,19:g.13054594A>G, hg38,19:g.12943780A>G",0.124,"haematopoietic_and_lymphoid_tissue, oesophagus","carcinoma, adenocarcinoma, haematopoietic_neoplasm, myelofibrosis, primary",0.0000045390585992,
441,375,K,E,,,,,,,,,,C,"NRD cleavage site, 375-377, ELM|PCSK cleavage site, 375-377, ELM",,COSMIC,,,"hg38,19:12943782-12943782","hg38,19:g.12943782A>G",0.055,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
442,375,K,R,,,,,,,,,,C,"NRD cleavage site, 375-377, ELM|PCSK cleavage site, 375-377, ELM",,COSMIC,,,"hg38,19:12943783-12943783","hg38,19:g.12943783A>G",0.032,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
443,376,R,C,,,,,,,,,,C,"NRD cleavage site, 375-377, ELM|PCSK cleavage site, 375-377, ELM",,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,19:13054599-13054599","hg19,19:g.13054599C>T",0.087,,,0.0000000000000000,
444,376,R,H,,,,,,,,,,C,"NRD cleavage site, 375-377, ELM|PCSK cleavage site, 375-377, ELM",,cBioPortal,"mds_iwg_2022, pptc_2019, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,19:13054600-13054600","hg19,19:g.13054600G>A",0.030,,,0.0000046415773937,
445,377,K,,,,,,,,,,,C,"NRD cleavage site, 375-377, ELM|PCSK cleavage site, 375-377, ELM",,,,,,,,,,,
446,378,E,Q,,,,,,,,,,C,,,cBioPortal,brca_mbcproject_2022,Invasive Breast Carcinoma,"hg19,19:13054605-13054605","hg19,19:g.13054605G>C",0.086,,,,
447,379,E,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",mds_iwg_2022,Myelodysplastic Syndromes,"hg19,19:13054610-13054610, hg38,19:12943796-12943796","hg19,19:g.13054610G>C, hg38,19:g.12943796G>C",0.073,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
448,380,E,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943798-12943798","hg38,19:g.12943798A>G",0.034,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia",0.0004415357594906,0.0001275347532203
449,381,E,A,,,,,,,,,,C,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","lung_msk_mind_2020, msk_met_2021","Lung, Mixed Cancer Types","hg19,19:13054615-13054615, hg38,19:12943801-12943801","hg19,19:g.13054615A>C, hg38,19:g.12943801A>C",0.054,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",0.0047760114194091,0.0012437810945274
450,381,E,G,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943801-12943801","hg38,19:g.12943801A>G",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
451,381,E,Q,,,,,,,,,,C,,,cBioPortal,brca_tcga_pub2015,Invasive Breast Carcinoma,"hg19,19:13054614-13054614","hg19,19:g.13054614G>C",0.036,,,,
452,382,A,V,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13054618-13054618","hg19,19:g.13054618C>T",0.027,,,,
453,383,E,K,,,,,,,,,,C,,,cBioPortal,"msk_access_2021, msk_met_2021",Mixed Cancer Types,"hg19,19:13054620-13054620","hg19,19:g.13054620G>A",0.031,,,,
454,384,D,E,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,19:13054625-13054625, hg38,19:12943811-12943811","hg19,19:g.13054625C>G, hg38,19:g.12943811C>G",0.010,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
455,384,D,G,,,,,,,,,,C,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13054624-13054624, hg38,19:12943810-12943810","hg19,19:g.13054624A>G, hg38,19:g.12943810A>G",,endometrium,"carcinoma, endometrioid_carcinoma",,
456,385,K,E,,,,,,,,,,C,,,COSMIC,,,"hg38,19:12943812-12943812","hg38,19:g.12943812A>G",0.063,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",0.0000050821271752,
457,385,K,N,,,,,,,,,,C,,,cBioPortal,"gbc_mskcc_2022, msk_met_2021","Gallbladder Cancer, Mixed Cancer Types","hg19,19:13054628-13054628","hg19,19:g.13054628G>T",0.028,,,0.0000101795675720,
458,386,E,G,,,,,,,,,,C,,,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pub, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,19:13054630-13054630, hg38,19:12943816-12943816","hg19,19:g.13054630A>G, hg38,19:g.12943816A>G",0.062,breast,carcinoma,,
459,387,D,,,,,,,,,,,D,,,,,,,,,,,,
460,388,D,E,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943823-12943823","hg38,19:g.12943823T>G",,large_intestine,"carcinoma, adenocarcinoma",,
461,388,D,Y,,,,,,,,,,D,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13054635-13054635","hg19,19:g.13054635G>T",0.135,,,,
462,389,E,D,,,,,,,,,,D,,,"cBioPortal,COSMIC","cesc_tcga, paad_qcmg_uq_2016","Cervical Squamous Cell Carcinoma, Pancreatic Adenocarcinoma","hg19,19:13054640-13054640, hg38,19:12943826-12943826","hg19,19:g.13054640G>C, hg19,19:g.13054640G>T, hg38,19:g.12943826G>C, hg38,19:g.12943826G>T",0.047,"cervix, pancreas","carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",,
463,389,E,K,,,,,,,,,,D,,,cBioPortal,brca_tcga_pub2015,Invasive Breast Carcinoma,"hg19,19:13054638-13054638","hg19,19:g.13054638G>A",0.077,,,,
464,390,D,E,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943829-12943829","hg38,19:g.12943829C>A",,liver,"other, neoplasm",,
465,390,D,H,,,,,,,,,,D,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,19:13054641-13054641","hg19,19:g.13054641G>C",0.063,,,,
466,391,K,,,,,,,,,,,D,,,,,,,,,,,,
467,392,D,G,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943834-12943834","hg38,19:g.12943834A>G",0.111,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, myelofibrosis, primary",,
468,393,E,,,,,,,,,,,D,,,,,,,,,,,,
469,394,D,,,,,,,,,,,D,,,,,,,,,,,,
470,395,E,,,,,,,,,,,D,,,,,,,,,,,,
471,396,E,,,,,,,,,,,D,,,,,,,,,,,,
472,397,D,,,,,,,,,,,D,,,,,,,,,,,,
473,398,E,D,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943853-12943853","hg38,19:g.12943853G>T",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, chronic_neutrophilic_leukaemia, haematopoietic_neoplasm, myeloproliferative_neoplasm",,0.0000637836458732
474,398,E,K,,,,,,,,,,D,,,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,19:13054665-13054665, hg38,19:12943851-12943851","hg19,19:g.13054665G>A, hg38,19:g.12943851G>A",0.115,lung,"carcinoma, adenocarcinoma",0.0000506098486766,
475,399,E,,,,,,,,,,,D,,,,,,,,,,,,
476,400,D,H,,,,,,,,,,D,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:13054671-13054671, hg38,19:12943857-12943857","hg19,19:g.13054671G>C, hg38,19:g.12943857G>C",0.082,lung,"carcinoma, squamous_cell_carcinoma",,
477,401,K,E,,,,,,,,,,D,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13054674-13054674","hg19,19:g.13054674A>G",0.037,,,,
478,401,K,T,,,,,,,,,,D,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:13054675-13054675","hg19,19:g.13054675A>C",0.069,,,,
479,402,E,,,,,,,,,,,D,,,,,,,,,,,,
480,403,E,K,,,,,,,,,,D,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,19:13054680-13054680, hg38,19:12943866-12943866","hg19,19:g.13054680G>A, hg38,19:g.12943866G>A",0.072,endometrium,"carcinoma, mixed_serous_and_endometrioid_carcinoma",,
481,404,D,E,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943871-12943871","hg38,19:g.12943871T>A",0.044,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,
482,405,E,D,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943874-12943874","hg38,19:g.12943874G>T",,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, essential_thrombocythaemia",,
483,405,E,Q,,,,,,,,,,D,,,COSMIC,,,"hg38,19:12943872-12943872","hg38,19:g.12943872G>C",0.080,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,
484,406,E,Q,,,,,,,,,,D,,,cBioPortal,brca_tcga_pub2015,Invasive Breast Carcinoma,"hg19,19:13054689-13054689","hg19,19:g.13054689G>C",0.068,,,,
485,407,E,,,,,,,,,,,D,,,,,,,,,,,,
486,408,D,,,,,,,,,,,D,,,,,,,,,,,,
487,409,V,,,,,,,,,,,D,,,,,,,,,,,,
488,410,P,L,,,,,,,,,,D,"TRAF2 binding site, 410-415, ELM",,"cBioPortal,COSMIC","msk_met_2021, skcm_tcga, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:13054702-13054702, hg38,19:12943888-12943888","hg19,19:g.13054702C>T, hg38,19:g.12943888C>T",0.022,skin,malignant_melanoma,,
489,411,G,D,,,,,,,,,,D,"TRAF2 binding site, 410-415, ELM",,cBioPortal,"ccle_broad_2019, lymphoma_cellline_msk_2020","Lymphoid, Mixed Cancer Types","hg19,19:13054705-13054705","hg19,19:g.13054705G>A",0.075,,,,
490,411,G,S,,,,,,,,,,D,"TRAF2 binding site, 410-415, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:13054704-13054704, hg38,19:12943890-12943890","hg19,19:g.13054704G>A, hg38,19:g.12943890G>A",0.068,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000000000000000,
491,412,Q,,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|TRAF2 binding site, 410-415, ELM",,,,,,,,,,,
492,413,A,S,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|TRAF2 binding site, 410-415, ELM",,COSMIC,,,"hg38,19:12943896-12943896","hg38,19:g.12943896G>T",0.014,thyroid,carcinoma,,
493,413,A,T,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|TRAF2 binding site, 410-415, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:13054710-13054710","hg19,19:g.13054710G>A",0.030,,,,
494,414,K,E,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|TRAF2 binding site, 410-415, ELM|KDEL retrieving signals, 414-417, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,19:13054713-13054713, hg38,19:12943899-12943899","hg19,19:g.13054713A>G, hg38,19:g.12943899A>G",,liver,"carcinoma, hepatocellular_carcinoma",,
495,415,D,E,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|TRAF2 binding site, 410-415, ELM|KDEL retrieving signals, 414-417, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,19:13054718-13054718, hg38,19:12943904-12943904","hg19,19:g.13054718C>G, hg38,19:g.12943904C>G",0.138,liver,"carcinoma, hepatocellular_carcinoma",0.0000131136075534,
496,416,E,K,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|KDEL retrieving signals, 414-417, ELM",,"cBioPortal,COSMIC","crc_apc_impact_2020, crc_msk_2017, msk_met_2021, rectal_msk_2022","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:13054719-13054719, hg38,19:12943905-12943905","hg19,19:g.13054719G>A, hg38,19:g.12943905G>A",0.255,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000043769422681,
497,417,L,,,,,,,,,,,D,"PDZ domain ligands, 412-417, ELM|KDEL retrieving signals, 414-417, ELM",,,,,,,,,,,
